1. Abbott

    0 Comments Leave a Comment

    1-15 of 912 1 2 3 4 ... 59 60 61 »
    1. Mentioned In 912 Articles

    2. Systems and methods to measure physiological flow in coronary arteries

      Systems and methods to measure physiological flow in coronary arteries
      In part, the disclosure relates to computer-based methods, and systems suitable for evaluating a subject to determine the appropriate diagnostic tools for assessing coronary arteries. This can include assessing various blood pressure values during a resting state (without inducing hyperemia). These systems and methods can assess a patient and identify coronary dominance on per patient basis. In turn, this assessment can be used to recommend whether a resting index is ...
      Read Full Article
      Mentions: Abbott
    3. CAlcified Lesion Intervention Planning Steered by OCT.

      CAlcified Lesion Intervention Planning Steered by OCT.
      Calcified lesions are very frequent among coronary artery disease stenotic lesions. The prevalence of calcifications ranges from 30 to 40% (by angiography evaluation) but is higher when analyzed by intra coronary imaging. Calcified lesions are very frequent among coronary artery disease stenotic lesions. The prevalence of calcifications ranges from 30 to 40% (by angiography evaluation) but is higher when analyzed by intra coronary imaging. The presence of calcifications increases the ...
      Read Full Article
      Mentions: Abbott
    4. Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries (CMD-MINOCA)

      Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries (CMD-MINOCA)
      To compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated byoptical coherence tomography(OCT), invasive and non-invasive coronary physiologic assessment.
      Read Full Article
      Mentions: Abbott
    5. Differences in Culprit Lesions Between Pre-menopausal and Postmenopausal Women with Acute Coronary Syndrome: An Optical Coherence Tomography Study

      Differences in Culprit Lesions Between Pre-menopausal and Postmenopausal Women with Acute Coronary Syndrome: An Optical Coherence Tomography Study
      ... predilatation was not used. The frequency-domain OCT C7 system and the Dragon Fly catheter (Lightlab Imaging/St. Jude Medical, Westford, Massachusetts, USA) were used for acquiring OCT images. With the C7 system, a 2.7-...
      Read Full Article
    6. The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease

      The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease
      Rationale: Peripheral arterial disease is a severe clinical problem with an increasing prevalence, due to an ageing population. Endovascular treatment, usually using stents, is recommended for most lesions in the femoropopliteal tract. The patency of these stents is influenced by several factors, including stent sizing and stent positioning. Current procedural planning of femoropopliteal disease is primarily based on single-plane digital subtraction angiographies (DSA). This modality provides a 2-dimensional image of ...
      Read Full Article
    7. 1-15 of 912 1 2 3 4 ... 59 60 61 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Abbott

    Abbott

    Abbott has cardiovascular and ophthalmic OCT.  (Abbot acquired St. Jude Medical, which acquired Lightlab Imaging).

  3. Quotes about Abbott

    1. OptiMedica's technology, combined with Abbott's global market presence, offers the potential to provide advanced cataract treatment options to more patients around the world.
      In Abbott completes $400M OptiMedica deal
    2. Surgeons should have the choice of the best and most innovative products to maximize clinical outcomes, manage their data, and optimize their workflow...That is why we agreed to expand our customer reach in the United States by making our products available additionally through Abbott.
      In Abbott Expands Cataract Surgery Product Portfolio through U.S. Distribution Agreement with Carl Zeiss Meditec